Characteristics and outcomes of MitraClip in octogenarians: Evidence from 1853 patients in the GIOTTO registry.


Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
01 Nov 2021
Historique:
received: 01 06 2021
revised: 22 07 2021
accepted: 04 08 2021
pubmed: 11 8 2021
medline: 21 10 2021
entrez: 10 8 2021
Statut: ppublish

Résumé

We aimed at appraising features and outcomes of patients undergoing MitraClip treatment according to their age. We queried the prospective GIse registry Of Transcatheter treatment of mitral valve regurgitaTiOn (GIOTTO) multicenter registry dataset including 19 Italian centers performing MitraClip implantation, distinguishing patients <80 vs ≥80 years of age. In total, 1853 patients were included, 751 (40.5%) octogenarians and 1102 (59.5%) non-octogenarians. Several baseline and procedural features were significantly different, including gender, regurgitation etiology, and functional class (all p < 0.05). In-hospital outcomes were similarly satisfactory, with death occurring in 18 (2.4%) and 32 (2.9%, p = 0.561), respectively, and improvement in mitral regurgitation in 732 (97.4%) and 1078 (97.8%, p = 0.746), respectively. After a mean follow-up of 15 months, death occurred in 152 (20.2%) and 264 (24.0%), and cardiac death in 85 (11.3%) and 138 (12.5%), respectively (both p > 0.05). Rehospitalization for heart failure and the composite of cardiac death or rehospitalization for heart failure were significantly less common in octogenarians: 63 (8.4%) vs 156 (14.2%, p < 0.001), and 125 (16.6%) vs 242 (22.0%, p = 0.005), respectively. Multivariable analysis showed that these differences were largely due to confounding features, as after adjustment for baseline, clinical and imaging characteristics no significant difference was found for the above clinical endpoints. Transcatheter mitral valve repair with the MitraClip in carefully selected octogenarians appears feasible and safe, and is associated with favorable clinical outcomes at mid-term follow-up.

Sections du résumé

BACKGROUND BACKGROUND
We aimed at appraising features and outcomes of patients undergoing MitraClip treatment according to their age.
METHODS METHODS
We queried the prospective GIse registry Of Transcatheter treatment of mitral valve regurgitaTiOn (GIOTTO) multicenter registry dataset including 19 Italian centers performing MitraClip implantation, distinguishing patients <80 vs ≥80 years of age.
RESULTS RESULTS
In total, 1853 patients were included, 751 (40.5%) octogenarians and 1102 (59.5%) non-octogenarians. Several baseline and procedural features were significantly different, including gender, regurgitation etiology, and functional class (all p < 0.05). In-hospital outcomes were similarly satisfactory, with death occurring in 18 (2.4%) and 32 (2.9%, p = 0.561), respectively, and improvement in mitral regurgitation in 732 (97.4%) and 1078 (97.8%, p = 0.746), respectively. After a mean follow-up of 15 months, death occurred in 152 (20.2%) and 264 (24.0%), and cardiac death in 85 (11.3%) and 138 (12.5%), respectively (both p > 0.05). Rehospitalization for heart failure and the composite of cardiac death or rehospitalization for heart failure were significantly less common in octogenarians: 63 (8.4%) vs 156 (14.2%, p < 0.001), and 125 (16.6%) vs 242 (22.0%, p = 0.005), respectively. Multivariable analysis showed that these differences were largely due to confounding features, as after adjustment for baseline, clinical and imaging characteristics no significant difference was found for the above clinical endpoints.
CONCLUSIONS CONCLUSIONS
Transcatheter mitral valve repair with the MitraClip in carefully selected octogenarians appears feasible and safe, and is associated with favorable clinical outcomes at mid-term follow-up.

Identifiants

pubmed: 34375704
pii: S0167-5273(21)01220-1
doi: 10.1016/j.ijcard.2021.08.010
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

65-71

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Arturo Giordano (A)

Unità Operativa di Interventistica Cardiovascolare, Pineta Grande Hospital, Castel Volturno, Italy.

Giuseppe Biondi-Zoccai (G)

Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy; Mediterranea Cardiocentro, Napoli, Italy. Electronic address: giuseppe.biondizoccai@uniroma1.it.

Filippo Finizio (F)

Unità Operativa di Interventistica Cardiovascolare, Pineta Grande Hospital, Castel Volturno, Italy.

Paolo Ferraro (P)

Unità Operativa di Emodinamica, Santa Lucia Hospital, San Giuseppe Vesuviano, Italy.

Paolo Denti (P)

PD: Department of Cardiac Surgery, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.

Antonio Popolo Rubbio (AP)

Department of Cardiology, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.

Anna Sonia Petronio (AS)

Cardiac Catheterization Laboratory, Cardiothoracic and Vascular Department, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.

Antonio L Bartorelli (AL)

Centro Cardiologico Monzino, IRCCS, Department of Biomedical and Clinical Sciences "Luigi Sacco", University of Milan, Italy.

Annalisa Mongiardo (A)

Division of Cardiology, University Magna Graecia, Catanzaro, Italy.

Francesco De Felice (F)

UOS Cardiologia Interventistica, Azienda Ospedaliera S. Camillo Forlanini, Rome, Italy.

Marianna Adamo (M)

Cardiothoracic Department, Spedali Civili Brescia, Brescia, Italy.

Matteo Montorfano (M)

Cardio-Thoracic-Vascular Department, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Cesare Baldi (C)

Interventional Cardiology, AOU San Giovanni e Ruggi, Salerno, Italy.

Giuseppe Tarantini (G)

Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padua, Padua, Italy.

Francesco Giannini (F)

GVM Care & Research Maria Cecilia Hospital, Cotignola, Italy.

Federico Ronco (F)

Interventional Cardiology, Ospedale Dell'Angelo, Mestre - Venice, Italy.

Ida Monteforte (I)

UOC Cardiologia Interventistica, AORN dei Colli, Naples, Italy.

Emmanuel Villa (E)

Cardiac Surgery and Transcatheter Valve Therapy Group, Poliambulanza Foundation Hospital, Brescia, Italy.

Maurizio Ferrario (M)

Division of Cardiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Luigi Fiocca (L)

Cardiovascular Department, ASST Papa Giovanni XXIII, Bergamo, Italy.

Fausto Castriota (F)

GVM Care & Research Maria Cecilia Hospital, Cotignola, Italy.

Corrado Tamburino (C)

Division of Cardiology, AOU Policlinico "G. Rodolico - San Marco", Università di Catania, Catania, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH